Transfer of morphine across the human placenta and its interaction with naloxone

Life Sciences

Volumn 65, Issue 22, 1999, Pages 2359-2371

  Kopecky, Ernest A ^a,b   Simone, Carmine ^a   Knie, Brenda ^a   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Clearance; Cotyledon; Fetus; In vitro perfusion; Morphine; Naloxone; Placenta; Placental transfer

Indexed keywords

MORPHINE; NALOXONE;

ARTICLE; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; FETUS; FETUS RISK; HUMAN; HUMAN TISSUE; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRENATAL DRUG EXPOSURE; TISSUE CULTURE; TISSUE PERFUSION; VASOCONSTRICTION;

ANALGESICS, OPIOID; BIOLOGICAL TRANSPORT; CHORIONIC GONADOTROPIN; DRUG INTERACTIONS; FEMALE; GLUCOSE; HUMANS; LACTIC ACID; MATERNAL-FETAL EXCHANGE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PERFUSION; PLACENTA; PREGNANCY; VASOCONSTRICTION;

EID: 0033595819     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00503-2     Document Type: Article

References (42)

1. K.A. Kaltenbach, Drug Alcohol Depend. 36 83-87 (1994).
2. B.N. Mclaughlin, R. Martin, J.C. Morrison, Clin. Perinatol. 12 551-569 (1985).
3. Motherisk Drug List. Toronto. (1993).
4. W.F. Rayburn and J.P. Lavin Jr., Obstet. Gynecol. 155 565-569 (1986).
5. A. Noronha, Clin. Perinatol. 2 695-713 (1985).
6. C.W. Howden, Prescribing in Pregnancy, P.C. Rubin (Ed), 19-25, British Medical Journal, London (1987).
7. P. Lee, Clin. Invest. Med. 8 328-332 (1985).
8. National Institutes of Health, National Pregnancy and Health Survey - Drug Use Among Women Delivering Live Births: 1992, National Institutes of Health, NIH Publication 96-3819, Rockville, MD (1996).
9. I.L. Stile, M. Fort, R.J. Wurzburger, S.S. Rodvold, S. Spector, I.M. Hiatt, T. Hegyi, Dev. Pharmacol. Therap. 10 454-459 (1987).
10. B. Noerr, Neonat. Network 11 77-79 (1992).
11. D.E. Fisher and J.B. Patton, Clin. Obstet. Gynaecol. 17 275-287 (1974).
12. J.J. Bonica, Principles and Practices of Obstetric Analgesia and Anesthesia, 247, FA Davis, Philadelphia (1967).
13. E. Gerdin, A. Rane, B. Lindberg, J. Perinat. Med. 18 305-312 (1990).
14. R.B. Clark, A.G. Beard, F.E. Greifenstein, D.L. Barclay, South. Med. J. 69 570-575 (1976).
15. P.A. Dailey, G.L. Brookshire, S.M. Shnider, T.K. Abboud, D.M. Kotelko, R. Noueihid, J.W. Thigpen, S.S. Khoo, J.A. Roya, S.E. Fouter, R.V. Brezys, U. Goebelsmann, M.W. Lo, Anesthesiol. Analg. 64 658-666 (1985).
16. R.A. Cohen and J.D. Coffman, Clin. Pharmacol. Therap. 28 541-544 (1980).
17. D.C. Dyer, J. Pharmacol. Exp. Therap. 175 565-570 (1970).
18. M. Di Tommaso, A. D'Alessandro, A. Farruggia, F. Branconi, Bio. Res. Preg. 7 111-112 (1986).
19. L.O. Derewlany, J.S. Leeder, R. Kumar, I.C. Radde, B. Knie, G. Koren, J. Pharmacol. Exp. Therap. 256 1107-1111 (1991).
20. L.O. Derewlany, B. Knie, G. Koren, J. Pharmacol. Exp. Therap. 269 761-765 (1994).
21. C. Simone, L.O. Derewlany, M. Oskamp, B. Knie, G. Koren, Am. J. Obstet. Gynecol. 170(Part 1) 1404-1410 (1994).
22. Diagnostic Products Corporation, Coat-A-Count Serum Morphine, 1-12, Diagnostic Products Corp., Los Angeles (1990).
23. Hybritech Incorporated, Tandem-R-HCG Immunoradiometric Assay, 1-4, Hybritech Incorp., San Diego (1995).
24. B. Brodie, J. Axelrod, R. Soberman, B. Levy, J. Biol. Chem. 179 25-29 (1949).
25. S. Hauguel, J.C. Challier, L. Cedard, G. Olive, Ped. Res. 17 729-732 (1983).
26. F.A. Manning, L.D. Platt, L. Sipos, Am. J. Obstet. Gynecol. 136 787-795 (1980).
27. D. Arduini, G. Rizzo, S. Dell'Acqua, S. Mancuso, C. Romanini, Am. J. Obstet. Gynecol. 156 474-478 (1987).
28. C. Simone, L.O. Derewlany, G. Koren, Clin. Perinatol. 21 463-481 (1994).
29. P.A. Glare and T.D. Walsh, Therap. Drug Monitor. 13 1-23 (1991).
30. B.A. Berkowitz, S.H. Ngai, J.C. Yang, J. Hempstead, S. Spector, Clin. Pharmacol. Therap. 17 626-635 (1975).
31. M.R. Juchau, Perinatal Pharmacology and Therapeutics, B.L. Mirkin (Ed), 71-118, Academic Press, New York (1976).
32. G.M. Pacifici and A. Rane, Br. J. Clin. Pharmacol. 13 732-735 (1982).
33. R.B. Clark and A.B. Seifen, Obstet. Gynecol. Ann. 12 165-197 (1983).
34. H.M. Vandenberghe, S.J. Soldin, S.M. Macleod, Therapeutic Drug Monitoring: A Continuing Education Program of The American Association of Clinical Chemistry, 11 1-5 (1982).
35. G.D. Olsen, Clin. Pharmacol. Therap. 17 31-35 (1975).
36. K. Haram, K. Augensen, S. Elsayed, Br. J. Obstet. Gynecol. 90 139-145 (1983).
37. B. Krauer, P. Dayer, R. Anner, Br. J. Obstet. Gynecol. 91 875-881 (1984).
38. A.H. Bardy, V.K. Hiilesmaa, K. Teramo, P.J. Neuvonen, Therap. Drug Monitor. 12 40-46 (1990).
39. S.J. Fortunato, R.E. Bawdon, K.F. Swan, E.C. Bryant, S. Sobhi, Am. J. Obstet. Gynecol. 167 1595-1599(1992).
40. A. Chang, C. Wood, M. Humphrey, M. Gilbert, C. Wagstaff, Br. J. Obstet. Gynecol. 83 56-61 (1976).
41. Du Pont Pharma, Narcan, (Product Monograph) Du Pont Merck Pharma Inc, Dorval (1991).
42. A.G. Goodman, T.W. Rall, A.S. Nies, P. Taylor (Eds), Goodman and Gilman's the Pharmacologic Basis of Therapeutics, 8th Ed. Pergamon Press, Elmsford (1990).